|
Randomized non-comparative trials: an oxymoron?
|
|
12
|
727
|
September 26, 2024
|
|
Interpreting the coefficient of a log transformed dependent variable
|
|
2
|
280
|
September 11, 2024
|
|
Causal inferences from RCTs- could “toy” clinical examples promote understanding?
|
|
13
|
558
|
September 2, 2024
|
|
Individual response
|
|
247
|
40008
|
August 21, 2024
|
|
Advice for appropriate causal model and analysis method
|
|
2
|
318
|
August 18, 2024
|
|
Summary table of different Cox PHM models to compare them
|
|
3
|
259
|
August 12, 2024
|
|
Use of percentage change in clinical trials
|
|
17
|
3121
|
July 22, 2024
|
|
Evaluating seizures in open-label studies
|
|
8
|
630
|
July 21, 2024
|
|
Appropriate to do lasso, then standard glm using variables with non-zero coef. from lasso?
|
|
1
|
283
|
July 2, 2024
|
|
Estimands from zero-inflated regression model
|
|
9
|
687
|
June 20, 2024
|
|
ITT analysis under equally high non-adherence in both arms in RCT
|
|
4
|
514
|
June 9, 2024
|
|
Can we think of competing-event as another form of non-event in terms of utility?
|
|
0
|
441
|
April 21, 2024
|
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
5
|
7278
|
April 11, 2024
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
589
|
February 23, 2024
|
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
3808
|
February 16, 2024
|
|
Does subtracting/or not, the mean-rank in Wilcoxon-Mann-Whitney make any difference?
|
|
4
|
616
|
February 1, 2024
|
|
Ranked analysis of ANCOVA
|
|
7
|
1610
|
January 21, 2024
|
|
AUC of each subgroup is smaller than overall AUC
|
|
7
|
4655
|
November 13, 2023
|
|
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times
|
|
2
|
938
|
October 3, 2023
|
|
About the interpret category
|
|
1
|
3162
|
October 3, 2023
|
|
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups?
|
|
2
|
865
|
September 4, 2023
|
|
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models
|
|
4
|
1104
|
August 29, 2023
|
|
Design of Experiments in Economics vs Medicine: a Decision Theory POV
|
|
6
|
2012
|
July 27, 2023
|
|
Inferences from summary data - without seeing the data for a Cox PH model, do chi square tests tell us anything?
|
|
5
|
421
|
July 24, 2023
|
|
Case-control study with and corresponding subgroup
|
|
2
|
765
|
July 20, 2023
|
|
Impact of Model Intercepts on Ordinal Logistic Regression Outcome
|
|
7
|
1293
|
June 22, 2023
|
|
P values and small sample size
|
|
6
|
984
|
June 20, 2023
|
|
Minimum PPV/NPV values to reach positive net benefit and net benefit avoided
|
|
10
|
1479
|
June 12, 2023
|
|
Outlier detection
|
|
3
|
1420
|
May 11, 2023
|
|
HR really close to 1 but significant - how to interpret and report?
|
|
9
|
1630
|
April 25, 2023
|